InvestDashboard.com



Incyte Corporation (INCY)



$68.03
52 Week Low
$124.28
2017-04-28 15:02:45 MDT
$153.15
52 Week High

Basic Info

Healthcare
Sector
Biotechnology
Industry
Nasdaq
Stock Exchange
United States
Country

Market Cap: $25,260,000,000Large Cap (Between $10B and $100B)
Analyst Recommendation:1.9Analysts say: Buy. (1=Strong Buy, 5=Strong Sell)
Beta: 1.82 Higher Volatility Stock (beta over 1). Stock will go up more when the market goes up, and go down more when the market goes down. Beta of 1 means stock would match the S&P 500 Index.

Fundamentals

ForwardPE: 169.74
5 Yr Est Growth: 39.47%
Yield: 0.00%
PEG-Y Ratio: 4.3
Expensive Growth. A PEGY Ratio of less than 1 is ideal. A PEGY Ratio of 2 or less is acceptable.

Technicals

% Above 50 DayMA: -10.02%
% Above 200 DayMA: 7.99%
INCY Performance 52 Weeks: 66.48%
S&P 500 Performance 52 Weeks: 13.50%
Mixed Trend. Short Term trend is down, but longer term trend is up. There is hope because 50 Day MA is still above 200 Day MA. Stock is closer to 52 Week High than 52 Week Low.
INCY outperforming S&P 500 by 52.98% the last 52 Weeks.

Profile


More Valuation

Price To Book: 55.38
Not so great value. Low Price to Book means better value. A P/B value of 5 or less is great. But consider other metrics and maybe the growth and yield makes it worth it.
EV to EBITDA: 121.26
Not a good value. A low EV to EBITDA ratio is great. Ideally, under 10. Under 17 is okay.

More Info

Field Value Average Comments
% Held By Insiders11.37% 17.28%Held by fewer than average Insiders.
% Held By Institutions86.50% 62.07%Institutional percentage greater than average. Institutional buying and selling can really move stock price.
Short % Of Float8.08% 07.02% Shorted by greater than average percent. Investors and traders do not believe in stock. But watch out for short squeezes pushing stock upwards.
Debt to Equity1.55 1.08 More Aggressive Financing. Each industry has different Debt/Equity standard. Higher than 1 means company is taking on more leverage.
Profit Margin %9.43%-00.18% Profit Margin is better than the average! Good job.
Operating Margin %14.83%-05.28% Operating Margin greater than average percent. Good.
Return on Equity %35.29%-08.79% Return on Equity greater than average percent. Good.
Return on Assets %7.75%-01.29% Return on Assets greater than average percent. Good.
Revenue Per Employee $1,132,653.06 $883,096.70 More than average Revenue Per Employee. This stock (or industry) could be very efficient.
Price to Cash 29.11 5.52 Higher than average Price to Cash. Meaning that the company has a lower percentage of cash as a percent of price. Cash can be good to cushion company during hard times, and as a potential source for buyouts or investments. However, some activists want the cash to be used by a company to buy its own stock, or to increase their dividend, or to invest the money.
CPEGY Ratio 4.15 2.26 Higher than average CPEGY Ratio. Ideally, a CPEGY should be less than 1 or less than 1.5. CPEGY is the PEG Ratio but incorporating the yield and subtracting Cash Per Share.

Quick Thoughts

PROS:
  1. Analysts like this stock: 1.9 (1=Strong Buy, 5=Strong Sell)

  2. Good 5 Yr Est Growth: 39.47%

  3. Stock is Above Long Term 200DMA: 7.99%

  4. Stock outperforming S&P 500 over last 52 weeks: 52.98%

  5. Profit Margin is positive: 9.43%

  6. Operating Margin is positive: 14.83%

  7. Return on Equity is positively good: 35.29%

  8. Return on Assets is positive: 7.75%

CONS:
  1. PEGY Ratio not ideal (greater than 2): 4.3

  2. High Forward PE: 169.74

  3. Stock is Below Short Term 50DMA: -10.02%

  4. Price to Cash Ratio (29.11) is greater than average. Company has less cash as a percent of price than the average.

  5. Price to Book is over 10: 55.38

  6. Worse than average EV/EBITDA: 121.26

  7. Shorted more than average: 8.08%


Headlines


Stock Chart


InvestDashboard.com INCY: Incyte Corporation

This page updated Thu Feb 1 22:00:01 MST 2018.